Download PDF
Thromb Haemost 1996; 75(05): 801-807
DOI: 10.1055/s-0038-1650370
Original Article
Schattauer GmbH Stuttgart

Production of Tissue-Type Plasminogen Activator (t-PA) and Type-1 Plasminogen Activator Inhibitor (PAI-1) in Mildly Cirrhotic Rat Liver

Taiichiro Seki
1   The Department of Agricultural and Biological Chemistry, Nihon University College of Bioresource Science, Tokyo, Japan
3   The Department of Human Genetics, The University of Michigan Medical School, Ann Arbor, USA
,
Hideo Imai
2   The Department of Pharmacology, Taisho Pharmaceutical Co., Ltd. Research Center, Saitama, Japan
,
Shigeyuki Uno
1   The Department of Agricultural and Biological Chemistry, Nihon University College of Bioresource Science, Tokyo, Japan
,
Toyohiko Ariga
1   The Department of Agricultural and Biological Chemistry, Nihon University College of Bioresource Science, Tokyo, Japan
,
Thomas D Gelehrter
3   The Department of Human Genetics, The University of Michigan Medical School, Ann Arbor, USA
› Author Affiliations
Further Information

Publication History

Received 28 August 1995

Accepted after resubmission 08 February 1996

Publication Date:
10 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

We have studied the production of tissue-type plasminogen activator (t-PA) and type-1 plasminogen activator inhibitor (PAI-1) in liver of normal rats and in rats with mild cirrhosis induced by carbon tetrachloride inhalation, to demonstrate the production of these fibrinolytic components and their pathophysiologic role in the liver in vivo. Immunohistochemical study of paraffin-embedded liver sections and fibrin autography of frozen sections showed that the normal rat liver produces very little t-PA or PAI-1. On the contrary, striking t-PA activity and both t-PA and PAI-1 antigens were observed in the cirrhotic liver. Both t-PA and PAI-1 in plasma were also markedly increased in the cirrhotic rats. Because the hepatocyte can internalize t-PA or PA/PAI-1 complexes from circulation, Northern blot analysis of the total liver RNA was performed to demonstrate the endogenous synthesis of t-PA and PAI-1 in the liver. Although the normal liver hardly expresses either t-PA or PAI-1 mRNA, striking t-PA and PAI-1 mRNA expression was observed in the liver of rats with mild cirrhosis.

These data demonstrate that t-PA and PAI-1 production is strongly upregulated in the liver in rats with mild cirrhosis. These fibrinolytic components, whose production is closely associated with liver failure, may play important roles in the regulation of hepatocyte proliferation and liver regeneration in vivo.

 

  • References

  • 1 Mayer M. Biomedical and biochemical aspects of the plasminogen activation system. ClinBiochem 1990; 23: 197-211
    PubMedGoogle Scholar
  • 2 Danø K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985; 44: 139-266
    PubMedGoogle Scholar
  • 3 Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN. Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 1990; 68: 1-19
    CrossrefPubMedGoogle Scholar
  • 4 Heaton JH, Kathju S, Gelehrter TD. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides. Mol Endocrinol 1992; 6: 53-60
    PubMedGoogle Scholar
  • 5 Healy AM, Gelehrter TD. Induction of plasminogen activator inhibitor-1 in Hep G2 human hepatoma cells by mediators of the acute phase response. J Biol Chem 1994; 269: 19095-19100
    PubMedGoogle Scholar
  • 6 Quax PHA, van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, van Berkel TJC, Kuiper J, Emeis JJ. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type-1 mRNA in rat tissue in vivo. J Biol Chem 1990; 265: 15560-15563
    PubMedGoogle Scholar
  • 7 Astrup T. Tissue activators of plasminogen. Fed Proc 1969; 25: 42-51
    PubMedGoogle Scholar
  • 8 Oshiba S, Ariga T. Purification and characterization of the biliary plasminogen activator, bilokinase. J Biol Chem 1983; 258: 622-628
    PubMedGoogle Scholar
  • 9 Ariga T, Oshiba S, Seki T, Imai H, Imai S, Sawai H. Studies on bilokinase, a biliary plasminogen activator: immunologic property and organ distribution. Thromb Res 1989; 56: 37-48
    CrossrefPubMedGoogle Scholar
  • 10 Seki T, Ariga T, Saito K, Sugawara T, Oshiba S. Hormonal regulation of plasminogen activator production by rat hepatocytes in primary culture. Thromb Res 1990; 58: 543-554
    CrossrefPubMedGoogle Scholar
  • 11 Seki T, Watanabe K, Saito K, Ariga T. Purification and characterization of hepatic plasminogen activator (h-PA) in the conditioned medium of rat hepatocytes in primary culture. Biosci Biotech Biochem 1993; 57: 1369-1371
    CrossrefPubMedGoogle Scholar
  • 12 Heaton JH, Nebes VL, O’Dell LG, Morris SM, Gelehrter TD. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator inhibitor gene expression in primary cultures of rat hepatocytes. Mol Endocrinol 1989; 3: 185-192
    CrossrefPubMedGoogle Scholar
  • 13 Heaton JH, Gelehrter TD. Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells. Mol Endocrinol 1989; 3: 349-355
    CrossrefPubMedGoogle Scholar
  • 14 Heaton JH, Gelehrter TD. Cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor messenger RNAs in rat hepatoma cells. Mol Endocrinol 1990; 4: 171-178
    CrossrefPubMedGoogle Scholar
  • 15 Thornton AJ, Bruzdzinski CJ, Raper SE, Gelehrter TD. Plasminogen activator inhibitor-1 is an immediate early response gene in regenerating rat liver. Cancer Res 1994; 54: 1337-1343
    PubMedGoogle Scholar
  • 16 Konkle BA, Schuster SJ, Kelly MD, Harjes K, Hassett DE, Bohrer M, Tavassoli M. Plasminogen activator inhibitor-1 messenger RNA expression is induced in rat hepatocytes in vivo by dexamethasone. Blood 1992; 79: 2636-2647
    PubMedGoogle Scholar
  • 17 Podor T, Hirsh JJ, Gelehrter TD, Zeheb R, Torry D, Guigoz Y, Sierra F, Gauldie J. Type 1 plasminogen activator is not an acute phase reactant in rats. Lack of IL-6 and hepatocyte-dependent synthesis. J Immunol 1993; 150: 225-235
    PubMedGoogle Scholar
  • 18 Lasierra J, Aza MJ, Vilades E, poblet S, Barrao F, Bayon E, Gonzalez J. Tissue plasminogen activator and plasminogen activator inhibitor in patients with liver cirrhosis. Fibrinolysis 1991; 5: 117-120
    PubMedGoogle Scholar
  • 19 Ferro D, Quintarelli CQ, Saliola M, Alessandri C, Basili S, Bonavita MS, Violi F. Prevalence of hyperfibrinolysis in patients with liver cirrhosis. Fibrinolysis 1993; 7: 59-62
    PubMedGoogle Scholar
  • 20 Kirchheimer JC, Huber K, Polterauer P, Binder BR. Urokinase antigen in plasma of patients with liver cirrhosis and hepatoma. Thromb Haemost 1985; 54: 617-618
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Leiper K, Croll A, Booth NA, Moore NR, Sinclair T, Bennett B. Tissue plasminogen activator, plasminogen activator inhibitors and activator-inhibitor complex in liver disease. J Clin Pathol 1994; 47: 214-217
    CrossrefPubMedGoogle Scholar
  • 22 Oshiba S, Imai H, Sawai H, Imai S, Takao K, Suzuki H, Ariga T. Hepatobiliary fibrinolysis in experimental liver cirrhosis. Nihon Univ J Med 1990; 32: 355-363
    PubMedGoogle Scholar
  • 23 McLean KE, McLean AEM, Sutton PM. Instant cirrhosis: An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. Br J Exp Path 1969; 50: 502-506
    PubMedGoogle Scholar
  • 24 Koneff AA. Adaptation of the Mallory-Azan staining methods to the anterior pituitary of the rat. Stain Technol 1938; 13: 49-52
    PubMedGoogle Scholar
  • 25 Schneider WC. Phosphorus compounds in animal tissue. I. Extraction and estimation of deoxypentose nucleic acid and of pentose nucleic acid. J Biol Chem 1945; 161: 293-303
    PubMedGoogle Scholar
  • 26 Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1995; 62: 315-323
    PubMedGoogle Scholar
  • 27 Zeheb R, Rafferty UM, Rodriguez MA, Andreasen P, Gelehrter TD. Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1. Thromb Haemost 1987; 58: 1017-1023
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Enzyme-Linked Immunosorbent Assay (ELISA). In: Current Protocols in Molecular Biology Ausubel FM. et al., eds John Wiley and Sons, Inc; New York: 1988: 11.2.2-11.2.5
  • 29 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal Biochem 1987; 162: 156-159
    PubMedGoogle Scholar
  • 30 Puissant C, Houdebine LM. An improvement of single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. BioTechniques 1990; 8: 148-149
    PubMedGoogle Scholar
  • 31 Ny T, Leonardsson G, Hsueh AJW. Cloning and characterization of a cDNA for rat tissue-type plasminogen activator. DNA 1988; 7: 671-677
    CrossrefPubMedGoogle Scholar
  • 32 Zeheb R, Gelehrter TD. Cloning and sequencing of cDNA for the rat PAI-1. Gene 1988; 73: 459-486
    CrossrefPubMedGoogle Scholar
  • 33 Fort P, Marty L, Piechaczyk M, Sabrouty SE, Dani CH, Jeanteur P, Blanchand JM. Various rat adult tissues express only one major mRNA species from the glyceralde-hyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acid Res 1985; 13: 1431-1442
    CrossrefPubMedGoogle Scholar
  • 34 Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 136: 6-13
    PubMedGoogle Scholar
  • 35 Todd AS. Fibrinolysis autographs. Nature 1958; 181: 495-496
    PubMedGoogle Scholar
  • 36 Deutsch DD, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1978; 170: 1095-1096
    PubMedGoogle Scholar
  • 37 Johnson GD, Holborw EJ. Immunofluorescence. In: Handbook of Experimental Immunology Weir DM. ed Blackwell Scientific Inc; Oxford - London - Edinburgh -Melbouren: 1973: 18.0-18.20
  • 38 Rijken DC, Otter M, Kuiper J, van Berkel TJC. Receptor mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells. Thromb Res 1990; 10: 63-71
    CrossrefPubMedGoogle Scholar
  • 39 Otter M, Kuiper J, Bos R, Rijken DC, van Berkel TJC. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Biochem J 1992; 284: 545-550
    CrossrefPubMedGoogle Scholar
  • 40 Bu G, Williams S, Strickland DK, Schwartz AL. Low density lipoprotein/a2-macro-globulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci USA 1992; 89: 7427-7431
    CrossrefPubMedGoogle Scholar
  • 41 Orth K, Willnow T, Herz J, Gething MJ, Sambrook J. Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator. J Biol Chem 1994; 269: 21117-21122
    PubMedGoogle Scholar
  • 42 Thornton AJ, Gelehrter TD. Human hepatocytes express the gene for type 1 plasminogen activator-inhibitor (PAI-1) in vivo. Fibrinolysis 1995; 9: 9-15
    PubMedGoogle Scholar
  • 43 Heaton JH, Kathju S, Gelehrter TD. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides. Mol Endocrinol 1992; 6: 53-60
    PubMedGoogle Scholar
  • 44 Kathju S, Heaton JH, Bruzdzinski CJ, Gelehrter TD. Synergistic induction of tissue-type plasminogen activator gene expression by glucocorticoids and cyclic nucleotides in rat HTC hepatoma cells. Endocrinology 1994; 135: 1195-1204
    CrossrefPubMedGoogle Scholar
  • 45 Schneiderman J, Sawdey M, Craig H, Thinnes T, Bordin G, Loskutoff DJ. Type 1 plasminogen activator inhibitor gene expression following partial hepatectomy. Am J Pathol 1993; 143: 753-762
    PubMedGoogle Scholar
  • 46 Kluft C, Verheijen JH, Jie AFH, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 1985; 45: 605-610
    CrossrefPubMedGoogle Scholar
  • 47 Juhan-Vague I, Aillaud MF, de Cock F, Philip JoetC, Arnaud C, Serradimigni A, Collen D. The fast-acting inhibitor of tissue plasminogen activator is an acute phase reactant protein. Prog in Fibrinol 1985; 7: 146-149
    PubMedGoogle Scholar
  • 48 Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-443
    CrossrefPubMedGoogle Scholar
  • 49 Seki T, Hagiya M, Shimonishi M, Nakamura T. Organization of the human hepatocyte growth factor-encoding gene. Gene 1991; 102: 213-219
    CrossrefPubMedGoogle Scholar
  • 50 Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeiner B, Daikuhara Y, Tsubouchi H, Blasi F, Comoglio PM. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992; 11: 4825-4833
    PubMedGoogle Scholar
  • 51 Mars WM, Zamegar R, Michalopoulos GK. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993; 143: 949-958
    PubMedGoogle Scholar
  • 52 Massague J. The transforming growth factor-p family. Annu Rev Cell Biol 1990; 6: 597-641
    CrossrefPubMedGoogle Scholar
  • 53 Strain AJ, Frazer A, Hill DJ, Milner RD. Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem Biophys Res Commun 1987; 145: 436-442
    CrossrefPubMedGoogle Scholar
  • 54 Russell WE, Coffey RJJ, Oullette AJ, Moses HL. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 1988; 85: 5126-5130
    CrossrefPubMedGoogle Scholar
  • 55 Westerhausen DRJ, Hopkins WE, Billadello JJ. Multiple transforming growth factor-P-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells. J Biol Chem 1991; 266: 1092-1100
    PubMedGoogle Scholar
  • 56 Wojta J, Nakamura T, Fabry A, Hufnagl P, Beckman R, McGrath K, Binder BR. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in Hep G2 cells. Blood 1994; 84: 151-157
    PubMedGoogle Scholar